EA201400249A1 - Ингибиторы nedd8-активирующего фермента - Google Patents

Ингибиторы nedd8-активирующего фермента

Info

Publication number
EA201400249A1
EA201400249A1 EA201400249A EA201400249A EA201400249A1 EA 201400249 A1 EA201400249 A1 EA 201400249A1 EA 201400249 A EA201400249 A EA 201400249A EA 201400249 A EA201400249 A EA 201400249A EA 201400249 A1 EA201400249 A1 EA 201400249A1
Authority
EA
Eurasian Patent Office
Prior art keywords
nedd8
inhibitors
activating enzyme
chemicals
nae
Prior art date
Application number
EA201400249A
Other languages
English (en)
Other versions
EA031067B1 (ru
Inventor
Эшли Сью Маккаррон
Тодд Б. Селлз
Метью Стирлинг
Стефен Г. Строуд
Original Assignee
Миллениум Фармасьютикалз, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Миллениум Фармасьютикалз, Инк. filed Critical Миллениум Фармасьютикалз, Инк.
Publication of EA201400249A1 publication Critical patent/EA201400249A1/ru
Publication of EA031067B1 publication Critical patent/EA031067B1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/32—Nitrogen atom
    • C07D473/34—Nitrogen atom attached in position 6, e.g. adenine

Abstract

Описаны химические вещества, которые представляют собой ингибиторы Nedd8-активирующего фермента (NAE), а именно соединение {(1S,2S,4R)-4-[(6-{[(1R,2S)-5-хлор-2-метокси-2,3-дигидро-1Н-инден-1-ил]амино}пиримидин-4-ил)окси]-2-гидроксициклопентил}метил сульфамат и его фармацевтически приемлемые соли; их твердые формы и их пролекарства. Также описаны способы применения этих химических веществ для лечения расстройств, таких как рак.
EA201400249A 2011-08-24 2012-08-23 ИНГИБИТОРЫ Nedd8-АКТИВИРУЮЩЕГО ФЕРМЕНТА EA031067B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161526830P 2011-08-24 2011-08-24
PCT/US2012/052007 WO2013028832A2 (en) 2011-08-24 2012-08-23 Inhibitors of nedd8-activating enzyme

Publications (2)

Publication Number Publication Date
EA201400249A1 true EA201400249A1 (ru) 2014-05-30
EA031067B1 EA031067B1 (ru) 2018-11-30

Family

ID=47747080

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201400249A EA031067B1 (ru) 2011-08-24 2012-08-23 ИНГИБИТОРЫ Nedd8-АКТИВИРУЮЩЕГО ФЕРМЕНТА

Country Status (28)

Country Link
US (3) US8809356B2 (ru)
EP (2) EP2748168A4 (ru)
JP (1) JP6038150B2 (ru)
KR (1) KR20140054288A (ru)
CN (1) CN103889988B (ru)
AR (1) AR087672A1 (ru)
AU (1) AU2012298813B2 (ru)
BR (1) BR112014004239A2 (ru)
CA (1) CA2846231C (ru)
CL (1) CL2014000441A1 (ru)
CO (1) CO6900148A2 (ru)
CR (1) CR20140128A (ru)
DO (1) DOP2014000037A (ru)
EA (1) EA031067B1 (ru)
EC (1) ECSP14013263A (ru)
GE (1) GEP201606522B (ru)
HK (1) HK1199252A1 (ru)
IL (1) IL231069B (ru)
MA (1) MA35439B1 (ru)
MX (1) MX2014002015A (ru)
MY (1) MY166889A (ru)
PE (1) PE20141146A1 (ru)
SG (2) SG11201400102WA (ru)
TN (1) TN2014000080A1 (ru)
TW (1) TWI577667B (ru)
UA (1) UA114894C2 (ru)
UY (1) UY34292A (ru)
WO (1) WO2013028832A2 (ru)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8008307B2 (en) 2006-08-08 2011-08-30 Millennium Pharmaceuticals, Inc. Heteroaryl compounds useful as inhibitors of E1 activating enzymes
EA031067B1 (ru) * 2011-08-24 2018-11-30 Миллениум Фармасьютикалз, Инк. ИНГИБИТОРЫ Nedd8-АКТИВИРУЮЩЕГО ФЕРМЕНТА
NZ628969A (en) 2012-02-17 2017-03-31 Millennium Pharm Inc Pyrazolopyrimidinyl inhibitors of ubiquitin-activating enzyme
US9593121B2 (en) 2012-08-03 2017-03-14 Millennium Pharmaceuticals, Inc. Indole substituted pyrrolopyrimidinyl inhibitors of Uba6
EP2764866A1 (en) 2013-02-07 2014-08-13 IP Gesellschaft für Management mbH Inhibitors of nedd8-activating enzyme
CA2916468C (en) * 2013-07-02 2019-07-23 Millennium Pharmaceuticals, Inc. Heteroaryl compounds useful as inhibitors of sumo activating enzyme
CN103948590A (zh) * 2014-05-22 2014-07-30 中国药科大学 Nedd8激活酶抑制剂及其医药用途
SG11201610476VA (en) 2014-07-01 2017-01-27 Millennium Pharm Inc Heteroaryl compounds useful as inhibitors of sumo activating enzyme
WO2017183927A1 (ko) * 2016-04-20 2017-10-26 한국화학연구원 신규한 헤테로고리 화합물, 이의 제조방법 및 이를 유효성분으로 함유하는 암의 예방 또는 치료용 약학적 조성물
WO2018213258A1 (en) * 2017-05-15 2018-11-22 Millennium Pharmaceuticals, Inc. Treatment of merlin-deficient tumors using nae inhibitors
WO2023025668A1 (en) 2021-08-25 2023-03-02 Asociación Centro De Investigación Cooperativa En Biociencias-Cic Biogune Methods for the generation of stem cell memory t cells for adoptive t cell therapy

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5194446A (en) 1989-06-12 1993-03-16 A. H. Robins Company, Incorporated Compounds having one or more aminosulfaonyloxy radicals useful as pharmaceuticals
WO1997005132A1 (en) 1995-07-28 1997-02-13 Cubist Pharmaceuticals, Inc. Aminoacyl adenylate mimics as novel antimicrobial and antiparasitic agents
EP1597255A1 (en) 2002-11-13 2005-11-23 Rigel Pharmaceuticals, Inc. Rhodanine derivatives and pharmaceutical compositions containing them
WO2005037845A1 (en) 2003-10-17 2005-04-28 Rigel Pharmaceuticals, Inc. Benzothiazole and thiazole[5,5-b] pyridine compositions and their use as ubiquitin ligase inhibitors
JP2008503591A (ja) 2004-06-22 2008-02-07 ライジェル ファーマシューティカルズ， インコーポレイテッド ユビキチンリガーゼ阻害剤
WO2006084281A1 (en) 2005-02-04 2006-08-10 Millennium Pharmaceuticals, Inc. Inhibitors of e1 activating enzymes
EP1989206B1 (en) 2006-02-02 2012-07-04 Millennium Pharmaceuticals, Inc. Inhibitors of e1 activating enzyme
US8008307B2 (en) 2006-08-08 2011-08-30 Millennium Pharmaceuticals, Inc. Heteroaryl compounds useful as inhibitors of E1 activating enzymes
RS51549B (en) * 2006-08-08 2011-06-30 Millennium Pharmaceuticals Inc. HETEROARIL UNITS USEFUL AS INVESTIGATIVE ENZYME E1 INHIBITORS
US9187482B2 (en) * 2009-05-14 2015-11-17 Millennium Pharmaceuticals, Inc. Hydrochloride salt of((1S,2S,4R)-4-{4-[(1S)-2,3-dihydro-1H-inden-1-ylamino]-7H-pyrrolo[2,3-d]pyrimidin-7-yl}-2-hydroxycyclopentyl)methyl sulfamate
EA031067B1 (ru) * 2011-08-24 2018-11-30 Миллениум Фармасьютикалз, Инк. ИНГИБИТОРЫ Nedd8-АКТИВИРУЮЩЕГО ФЕРМЕНТА
KR101987861B1 (ko) * 2011-11-03 2019-06-11 밀레니엄 파머슈티컬스 인코퍼레이티드 Nedd-8 활성화 효소 억제제 및 저메틸화제의 투여

Also Published As

Publication number Publication date
SG11201400102WA (en) 2014-03-28
ECSP14013263A (es) 2014-04-30
IL231069B (en) 2018-02-28
MY166889A (en) 2018-07-24
UA114894C2 (uk) 2017-08-28
PE20141146A1 (es) 2014-09-21
MX2014002015A (es) 2014-03-27
IL231069A0 (en) 2014-03-31
US20130150388A1 (en) 2013-06-13
WO2013028832A3 (en) 2013-05-02
EP2748168A4 (en) 2015-04-22
TN2014000080A1 (en) 2015-07-01
HK1199252A1 (en) 2015-06-26
US20150011572A1 (en) 2015-01-08
CN103889988B (zh) 2018-05-04
CO6900148A2 (es) 2014-03-20
WO2013028832A2 (en) 2013-02-28
AU2012298813B2 (en) 2016-07-28
US9850214B2 (en) 2017-12-26
MA35439B1 (fr) 2014-09-01
EP2748168A2 (en) 2014-07-02
SG10201601023UA (en) 2016-03-30
JP2014524476A (ja) 2014-09-22
NZ622220A (en) 2016-04-29
DOP2014000037A (es) 2014-04-15
KR20140054288A (ko) 2014-05-08
CR20140128A (es) 2014-05-15
CA2846231A1 (en) 2013-02-28
EA031067B1 (ru) 2018-11-30
BR112014004239A2 (pt) 2017-03-21
CN103889988A (zh) 2014-06-25
CL2014000441A1 (es) 2014-09-26
US8809356B2 (en) 2014-08-19
AR087672A1 (es) 2014-04-09
GEP201606522B (en) 2016-08-10
TW201313689A (zh) 2013-04-01
CA2846231C (en) 2017-06-20
UY34292A (es) 2013-04-05
AU2012298813A1 (en) 2013-05-02
JP6038150B2 (ja) 2016-12-07
EP3323414A1 (en) 2018-05-23
TWI577667B (zh) 2017-04-11
US20180290983A1 (en) 2018-10-11

Similar Documents

Publication Publication Date Title
EA201400249A1 (ru) Ингибиторы nedd8-активирующего фермента
EA201491012A1 (ru) Гетероциклические ингибиторы глютаминазы
EA201391290A1 (ru) Гетероциклические модуляторы синтеза липидов
PH12018502102A1 (en) Pyrrolotriazine compounds as tam inhibitors
EA201490545A1 (ru) СОЕДИНЕНИЯ И КОМПОЗИЦИИ В КАЧЕСТВЕ ИНГИБИТОРОВ КИНАЗЫ С-Kit
MX2016014248A (es) Compuestos polifluorados que actuan como inhibidores de la tirosina cinasa de bruton.
EA201792214A1 (ru) Соединения замещенного хиназолина
EA201590975A1 (ru) Ингибиторы prmt5 и их применение
EA201490542A1 (ru) Соединения и композиции в качестве pdgfr киназных ингибиторов
EA201290807A1 (ru) Циклобутановые и метилциклобутановые производные в качестве ингибиторов янус-киназы
EA201301019A1 (ru) Бензодиоксановые ингибиторы продуцирования лейкотриена
EA201590230A1 (ru) Соединения пиразолопиримидина в качестве ингибиторов киназ
EA201391528A1 (ru) Ингибиторы тирозинкиназы
EA201491786A1 (ru) ТРИАЗОЛОНЫ В КАЧЕСТВЕ ИНГИБИТОРОВ mPGES-1
EA201491579A1 (ru) Соединения оксазолидин-2-она и их применения в качестве ингибиторов pi3k
EA201690752A1 (ru) Ингибиторы g12c kras
EA201491356A1 (ru) Ингибиторы протеинкиназ (варианты), их применение для лечения онкологических заболеваний и фармацевтическая композиция на их основе
EA201391274A1 (ru) Аминохинолины в качестве ингибиторов киназ
EA201400412A1 (ru) ЗАМЕЩЕННЫЕ БЕНЗИЛИНДАЗОЛЫ ДЛЯ ПРИМЕНЕНИЯ В КАЧЕСТВЕ ИНГИБИТОРОВ Bub1 КИНАЗЫ ДЛЯ ЛЕЧЕНИЯ ГИПЕРПРОЛИФЕРАТИВНЫХ ЗАБОЛЕВАНИЙ
EA201500298A1 (ru) Алкоксипиразолы в качестве активаторов растворимой гуанилатциклазы
EA201500182A1 (ru) 4-МЕТИЛ-2,3,5,9,9b-ПЕНТААЗАЦИКЛОПЕНТА[a]НАФТАЛИНЫ
EA201270752A1 (ru) Ингибиторы киназы и способ лечения злокачественной опухоли с их помощью
EA201370166A1 (ru) Содержащие диарилацетиленгидразид ингибиторы тирозинкиназы
EA201490537A1 (ru) СОЕДИНЕНИЯ И КОМПОЗИЦИИ В КАЧЕСТВЕ ИНГИБИТОРОВ КИНАЗЫ C-Kit
EA201691293A1 (ru) Гетероарильные производные бутановой кислоты в качестве ингибиторов lta4h

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG TJ TM RU